Aptorum Group and DiamiR Biosciences Merge to Enhance Biotech Capabilities in Diagnostics and Therapeutics
Aptorum Group and DiamiR Biosciences have announced a definitive merger agreement, combining Aptorum’s therapeutic assets with DiamiR’s diagnostic technologies to address unmet medical needs in the biotechnology sector.
2 minutes to read